Level of retinoblastoma protein expression correlates with p16 (MTS-1/INK4A/CDKN2) status in bladder cancer

Oncogene

Volumn 18, Issue 5, 1999, Pages 1197-1203

  Benedict, William F ^a   Lerner, Seth P ^b   Zhou, Jain ^a   Shen, Xiaohua ^a   Tokunaga, Hideo ^b   Czerniak, Bogdan ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Bladder cancer; p16; Prognosis; RB

Indexed keywords

PROTEIN P16; RETINOBLASTOMA PROTEIN;

ARTICLE; BLADDER CANCER; CHROMOSOME 9P; GENE OVEREXPRESSION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

BIOPSY; CHROMOSOMES, HUMAN, PAIR 9; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYSTECTOMY; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; MODELS, BIOLOGICAL; MUTATION; PROGNOSIS; RETINOBLASTOMA PROTEIN; SEQUENCE DELETION; URINARY BLADDER NEOPLASMS;

EID: 0033521887     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202452     Document Type: Article

References (35)

1. Benedict WF, Xu H-J, Hu S-X and Takahashi R. (1990). J. Clin. Invest., 85, 988-993.
2. Cairns P, Mao L, Merlo A, Lee DJ, Schwab D, Eby Y, Tokino K, Van de Riet P, Blaugrund JE and Sidransky D. (1994). Science, 265, 415-416.
3. Chaturvedi V, Li L, Hodges S, Johnston D, Ro JY, Logothetis C, von Eschenbach AC, Batsakis JG and Czerniak B. (1997). Oncogene, 14, 2059-2070.
4. Cordon-Cardo C, Wartinger D, Petrylak D, Dalbagni G, Fair WR, Fuks Z and Reuter VE. (1992). J. Natl. Cancer Inst., 84, 1251-1256.
5. Cordon-Cardo C, Zhang Z-F, Dalbagni G, Drobnjak M, Charytonowicz Hu S-X, Xu H-J, Reuter VE and Benedict WF. (1997). Cancer Res., 57, 1217-1221.
6. Cote R, Dunn MD, Chatterjee SJ, Stein JP, Shi S-R, Tran Q-C, Hu S-X, Xu H-J, Groshen S, Taylor CR, Skinner DG and Benedict WF. (1998). Cancer Res., 58, 1090-1094.
7. Dib C, Faure S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, Marc S, Hazan J, Seboun E, Lathrop M, Cyapay G, Morissette J and Weissenbach J. (1996). Nature (Lond.), 380, 152-154.
8. Ezhevsky SA, Nagahara H, Vocero-Akbani, Gius DR, Wei MC and Dowdy SF. (1997). Proc. Natl. Acad. Sci. USA, 94, 10699-10704.
9. Fang X, Jin X, Xu H-J, Liu L, Peng H-Q, Hogg D, Roth JA, Yu Y, Xu F, Bast RC and Mills GB. (1998). Oncogene, 16, 1-8.
10. Grossman HB, Liebert M, Antelo M, Dinney CPN, Hu S-X, Palmer L and Benedict WF. (1998). Clin. Cancer. Res., 4, 829-834.
11. Horowitz JM, Park S-H, Bogenmann E, Cheng J-C, Yandell D, Minna J, Dryja TP and Weinberg RA. (1990). Proc. Natl. Acad. Sci., USA, 87, 2775-2779.
12. Ishikawa J, Xu H-J, Hu S-X, Yandell DW, Maeda S, Kamidono S, Benedict WF and Takahashi R. (1991). Cancer Res., 51, 5376-5734.
13. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS III, Johnson BE and Skolnick MH. (1997). Science, 264, 436-440.
14. Kratzke RA, Greatens TM, Rubins JB, Maddaus MA, Niewoehner DE, Niehans GA and Geradts J. (1996). Cancer Res., 56, 3415-3420.
15. Logothetis CJ, Xu H-J, Ro JY, Hu S-X, Sahin A, Ordonez N and Benedict WF. (1992). J. Natl. Cancer Inst., 84, 1256-1261.
16. Lukas J, Parry D, Aagaarad L, Mann D, Bartkova J, Strauss M, Peters G and Bartek J. (1995). Nature (Lond.), 375, 503-506.
17. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB and Sidransky D. (1995). Nat. Med., 1, 686-692.
18. Okamoto A, Demetrick D, Spillare EA, Hagiwara K, Hussain SP, Bennett WP, Forrester K, Gerwin B, Serrano M, Beach DH and Harris CC. (1994). Proc. Natl. Acad. Sci. USA, 91, 11045-11049.
19. Orlow I, Lacombe L, Hannon GJ, Serrano M, Inmaculada P, Guido D, Reuter VE, Zhang Z-F, Beach D and Cordon-Cardo CJ. (1995). Natl. Cancer Inst., 87, 1524-1529.
20. Otterson GA, Kratzke RA, Coxton A, Kim YW and Kaye FJ. (1994). Oncogene, 9, 3375-3378.
21. Packenham JP, Taylor JA, Anna CH, White CM and Devereux TR. (1995). Mol. Carcinog., 14, 147-151.
22. Pomerantz J, Schreiber-Agus N, Liegeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee H-W, Cordon-Cardo C and DePinho RA. (1998). Cell, 92, 713-723.
23. Quelle DE, Zindy F, Ashmun RA and Sheer CJ. (1995). Cell, 83, 993-1000.
24. Reed AL, Califano J, Cairns P, Westra WH, Jones RM, Koch W, Ahrendt S, Eby Y, Sewell D, Nawroz H, Bartek J and Sidransky D. (1996). Cancer Res., 56, 3630-3633.
25. Sakaguchi M, Fuji Y, Hirabayashi H, Yoon H-E, Komoto Y, Oue T, Kusafuka T, Okada A and Matsuda H. (1996). Int. J. Cancer, 65, 442-445.
26. Shapiro GI, Edwards CD, Kobzik L, Godleski J, Richards W, Sugarbaker DL and Rollins B. (1995). Cancer Res., 55, 505-509.
27. Spruck CK, Gonzalez-Zulueta M, Shibata A, Simoneau AR, Lin M-F, Gonzales F, Tsai YC and Jones PA. (1994). Nature (Lond.), 370, 183-184.
28. Williamson MP, Elder PA, Shaw ME, Devlin J and Knowles MA. (1995). Hum. Mol. Gen., 4, 1569-1577.
29. Wong DJ, Barrett MT, Stoger R, Edmond M and Reid BJ. (1997). Cancer Res., 57, 2619-2622.
30. Xu H-J, Cagle PT, Hu S-X, Li J and Benedict WF. (1996). Clin. Cancer. Res., 2, 1169-1176.
31. Xu H-J, Cairns P, Hu S-X, Knowles MA and Benedict WF. (1993). Int. J. Cancer, 53, 781-784.
32. Xu H-J, Hu S-H and Benedict WF. (1991). Oncogene, 6, 1139-1146.
33. Xu H-J, Hu S-H, Hashimoto T, Takahashi R and Benedict WF. (1989). Oncogene, 4, 807-812.
34. Yeager T, Stadler W, Belair C, Puthenveettil J, Olopade O and Reznikoff C. (1995). Cancer Res., 55, 493-497.
35. Zhang Y, Xiong Y and Yarbrough WG. (1998). Cell, 92, 725-734.